Healthcare
•3753 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3753)
| Company | Market Cap | Price |
|---|---|---|
|
DXCM
DexCom, Inc.
DexCom's core product is continuous glucose monitoring (CGM), i.e., glucose monitoring devices sold as CGM systems.
|
$27.27B |
$69.58
+0.48%
|
|
JBL
Jabil Inc.
Aseptic filling and dry oral dosage capabilities via Pharmaceutics International (Pii) reflect contract manufacturing services in pharma.
|
$26.85B |
$251.39
-0.71%
|
|
STE
STERIS plc
STERIS manufactures surgical equipment, including sterilizers and endoscope-related devices used in operating rooms and infection prevention.
|
$26.46B |
$268.63
+0.14%
|
|
SHG
Shinhan Financial Group Co., Ltd.
Health insurance is a significant component of SHG's insurance offerings.
|
$26.34B |
$53.85
-0.46%
|
|
BNTX
BioNTech SE
The company is pivoting toward oncology with immunotherapies, making Biotech - Oncology a core product/business focus.
|
$26.20B |
$109.00
+2.76%
|
|
VLTO
Veralto Corporation
Veralto may offer laboratory testing and advisory services around water quality testing and compliance.
|
$25.48B |
$102.23
-0.92%
|
|
BIIB
Biogen Inc.
Biogen's LEQEMBI is an Alzheimer's disease therapeutic, a direct product the company manufactures and sells.
|
$24.11B |
$164.38
-2.48%
|
|
WAT
Waters Corporation
Waters supplies diagnostic instruments used in laboratories for analytical testing and qualification workflows.
|
$23.06B |
$387.34
-1.84%
|
|
LH
Labcorp Holdings Inc.
Labcorp offers liquid biopsy tests (e.g., MRD portfolios) as part of its oncology testing portfolio.
|
$22.51B |
$270.99
+0.78%
|
|
RVMD
Revolution Medicines, Inc.
Clinical-stage biotech focused on oncology; primary products are RAS(ON) inhibitors for cancer.
|
$22.48B |
$120.36
-2.36%
|
|
CNC
Centene Corporation
Centene's core business is providing health insurance (Medicaid/Medicare and Marketplace) via managed care programs, making Health Insurance its direct product/service.
|
$22.47B |
$45.77
-3.17%
|
|
CHD
Church & Dwight Co., Inc.
Waterpik dental water flossers and related oral-care devices are dental equipment products.
|
$22.07B |
$90.61
+0.20%
|
|
ILMN
Illumina, Inc.
Sequencing instruments and related medical device equipment are Illumina's core manufactured products sold to researchers and clinical labs.
|
$21.77B |
$141.63
-2.53%
|
|
DGX
Quest Diagnostics Incorporated
Quest provides laboratory testing services and advisory/regulatory support for microbiology and analytical workflows.
|
$21.19B |
$189.49
-0.40%
|
|
UTHR
United Therapeutics Corporation
UTHR's core PAH/CV therapy portfolio centers on prostacyclin cardiovascular drugs, including Tyvaso, Remodulin, Orenitram, and Ralinepag (where applicable).
|
$21.03B |
$464.94
-1.49%
|
|
INCY
Incyte Corporation
Incyte's business is centered on oncology-focused therapeutics, including Monjuvi and a broad cancer pipeline.
|
$20.74B |
$106.17
+0.88%
|
|
GMAB
Genmab A/S
Genmab is a biotechnology company focused on oncology therapeutics, fitting Biotech - Oncology.
|
$20.69B |
$32.26
-4.70%
|
|
PODD
Insulet Corporation
Insulet's core business is medical devices and equipment, anchored by the Omnipod insulin pump platform.
|
$20.25B |
$287.73
+0.43%
|
|
BWXT
BWX Technologies, Inc.
Radiopharmaceuticals for nuclear medicine imaging and diagnostics.
|
$19.91B |
$217.84
+2.15%
|
|
EXAS
Exact Sciences Corporation
Oncotype DX is a genomic assay used as a companion diagnostic in oncology, and the company discusses companion diagnostic capabilities and leadership in Precision Oncology.
|
$19.39B |
$102.46
+0.12%
|
|
SNA
Snap-on Incorporated
RS&I segment includes diagnostic equipment and repair information software platforms.
|
$18.85B |
$361.30
-0.59%
|
|
WST
West Pharmaceutical Services, Inc.
West designs and manufactures medical devices and delivery systems (e.g., autoinjectors, prefilled syringes).
|
$18.68B |
$259.81
-7.01%
|
|
IFF
International Flavors & Fragrances Inc.
DEB and enzyme-based biotechnologies are core to IFF's Health & Biosciences innovation and product offerings.
|
$18.37B |
$71.71
+1.24%
|
|
THC
Tenet Healthcare Corporation
Tenet operates hospitals and hospital-based care delivering inpatient and outpatient services.
|
$17.38B |
$196.82
-2.24%
|
|
ZBH
Zimmer Biomet Holdings, Inc.
Zimmer Biomet's core orthopedic devices business centers on joint implants (hips and knees) and related prosthetics.
|
$17.30B |
$87.33
-1.60%
|
|
MEDP
Medpace Holdings, Inc.
Medpace's core business is a specialized full-service CRO delivering Phase I–IV clinical development services.
|
$17.16B |
$610.38
-1.24%
|
|
HOLX
Hologic, Inc.
Panther Panther Fusion molecular diagnostics platform and Aptima/BV/CV/TV assays are diagnostic equipment sold by Hologic.
|
$16.68B |
$74.98
-0.05%
|
|
COO
The Cooper Companies, Inc.
CooperVision and CooperSurgical primarily manufacture ophthalmology devices and related vision-care products, fitting Ophthalmology Devices.
|
$16.38B |
$82.38
+0.09%
|
|
MRNA
Moderna, Inc.
Direct vaccines products (Spikevax and pipeline vaccines) are Moderna's core revenue drivers and product line.
|
$16.28B |
$41.83
+6.28%
|
|
ROIV
Roivant Sciences Ltd.
Immunovant's FcRn-targeting therapies (e.g., IMVT-1402, batoclimab) are monoclonal antibody therapeutics.
|
$15.80B |
$23.11
-0.79%
|
|
NDSN
Nordson Corporation
Atrion's medical components and medical device technologies place Nordson in the medical devices & biometrics space.
|
$15.28B |
$271.77
-0.05%
|
|
ULS
UL Solutions Inc.
UL Solutions offers Laboratory Testing & Advisory Services, including regulatory advisory and compliance support.
|
$15.07B |
$74.97
-2.79%
|
|
VTRS
Viatris Inc.
Viatris is a large-scale producer of generic medicines and biosimilars, core to its business.
|
$14.99B |
$12.86
+0.12%
|
Showing page 4 of 38 (3753 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
